Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study

Abstract

Long-term performance of the Micra transcatheter pacemaker remains consistent with previously reported data. Few patients experienced major complications through 12 months of follow-up, and all patient subgroups benefited as compared to transvenous pacemaker historical control group.